Immunovant Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: IMVT
Share price (11/6/26): $30.53
Market cap (11/6/26): $6.306 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from DEFA14A 78 pages Share Exchange Agreement Dated September 29, 2019 by and Among Immunovant Sciences Ltd., a Bermuda Exempted Limited Company, the Stockholders of the Company, Roivant Sciences Ltd., a Bermuda Exempted Limited Company, and Health Sciences Acquisitions Corporation, a Delaware Corporation

from 8-K 78 pages Share Exchange Agreement Dated September 29, 2019 by and Among Immunovant Sciences Ltd., a Bermuda Exempted Limited Company, the Stockholders of the Company, Roivant Sciences Ltd., a Bermuda Exempted Limited Company, and Health Sciences Acquisitions Corporation, a Delaware Corporation